Global Pharmaceuticals & Biotech Undervalued Dividend Payers

Johnson & Johnson

Market Cap: US$493.4b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Roche Holding

Market Cap: CHF 288.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Merck

Market Cap: US$270.2b

Operates as a healthcare company worldwide.

Gilead Sciences

Market Cap: US$150.6b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Pfizer

Market Cap: US$144.6b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Sanofi

Market Cap: €100.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

CSL

Market Cap: AU$84.1b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Takeda Pharmaceutical

Market Cap: JP¥8.0t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.5t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Shionogi

Market Cap: JP¥2.5t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥102.1b

Engages in the pharmaceutical business in China.

CSPC Pharmaceutical Group

Market Cap: HK$103.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Qiagen

Market Cap: US$10.3b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Krka d. d

Market Cap: €6.4b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥48.3b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

H. Lundbeck

Market Cap: DKK 41.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Hikma Pharmaceuticals

Market Cap: UK£3.5b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Dong-E-E-JiaoLtd

Market Cap: CN¥32.2b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

China Medical System Holdings

Market Cap: HK$33.8b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Livzon Pharmaceutical Group

Market Cap: CN¥29.4b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$29.0b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Grand Pharmaceutical Group

Market Cap: HK$27.7b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Santen Pharmaceutical

Market Cap: JP¥506.4b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Apeloa PharmaceuticalLtd

Market Cap: CN¥18.7b

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Lotus Pharmaceutical

Market Cap: NT$75.5b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥16.6b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.4b

Researches, develops, produces, and markets pharmaceuticals in China.

Tecan Group

Market Cap: CHF 1.8b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Jiang Zhong PharmaceuticalLtd

Market Cap: CN¥14.5b

Engages in the manufacture of pharmaceutical products in China.

SSY Group

Market Cap: HK$8.9b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Wuhan Keqian BiologyLtd

Market Cap: CN¥7.4b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

Genomma Lab Internacional. de

Market Cap: Mex$16.8b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Pulike Biological Engineering

Market Cap: CN¥4.4b

Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.

Duopharma Biotech Berhad

Market Cap: RM 1.3b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.